DCL: Explanation for the consolidated profit in Quarter 4, 2014

Cuu Long Pharmaceutical Joint Stock Corporation explained the fluctuation in profit in the consolidated financial statements for Quarter 4/2014 compared to Quarter 4/2013 as follows:

-          Profit after tax in Quarter 4/2014: VND4,990,745,420

-          Profit after tax in Quarter 4/2013: VND3,629,602,118

Compared to the same period of last year, the profit after tax in the consolidated financial statements for Quarter 4/2014 increased VND1,361,143,302 (more than 10%) because:

-          The company’s sales strategy focuses on staples with competitive advantage and high gross profit, so the ratio of gross profit to net revenue increased 0.8% compared to the same period.

-          The company sought funding resources with low interest rates. This led the decrease in the borrowing expense. So the borrowing expense in Quarter 4/2014 was VND4.4 billion, decreased VND3.4 billion against Quarter 4/2013.

HOSE

>   VSI: Explanation for parent company and consolidated business result in Q4, 2014 (25/02/2015)

>   HU3: Explanation for business result in Q4.2014 (25/02/2015)

>   STB: Explanation for separate business result in Quarter 4, 2014 (25/02/2015)

>   STB: Explanation for consolidated business result in Quarter 4, 2014 (25/02/2015)

>   FCM: Explanation for business result in Quarter 4, 2014 (25/02/2015)

>   APC: Explanation for business result in Q4.2014 (Single-entity FS) (25/02/2015)

>   APC: Explanation for business result in Q4.2014 (Consolidated FS) (25/02/2015)

>   TNA: Business result in the first 01 month of 2015 (26/02/2015)

>   MWG: Information on the 2015 Annual General Meeting of Shareholders (26/02/2015)

>   GTN: The record date for the 2015 AGM (26/02/2015)